This ad has expired

For Sale : Votrient to treat metastatic renal cell carcinoma

Posted on September 16, 2014 04:10 am

Details:

Votrient (Pazopanib is targeted therapy drug approved for treatment soft tissue sarcoma and metastatic renal cell carcinoma (kidney cancer). Votirnet works by blocking cellular enzymes called tyrosine kinases inhibitor that are important for cell growth and survival. The recommended dose of pazopanib is 800 mg taken once a day should be taken on an empty stomach, at least 1 hour before or 2 hours after a meal, for the best effect.Anticancer Medicine Price : $ 22 per pillShipping Time : 15 to 20 daysFor more please visit :

Other Active Ads for Health & Beauty in Toronto - GTA